20 December 2011
1. Apologies
2. Quorum
To confirm that the meetings are quorate before they proceed further.
Standing Orders state that no business shall be transacted at a meeting unless at least 1/3 of the whole number of the Chairman and members (including at least 1 officer member and 1 non-officer member), is present.
3. Declarations of Interest
Members to declare any interests, financial or otherwise.
4. Minutes
To approve the minutes of the Board meetings held on 8 September 2011.
5. Matters Arising
6. Chair's Verbal Report
7. Chief Executive's Report
To note the Report of the Chief Executive on matters of interest and approve the winter plan.
Items for Approval
Performance Reports
10. To note the Report of the Director of Finance on Performance.
11. To note the Report of the Director of Finance on Finance.
12. To note the Report of the Deputy Chief Executive/Director of Quality on Quality.
Transition to Clinical Commissioning Groups
Items for Noting
14. To note the Report of the Director of Workforce on Organisational Development.
15. To note the Annual Report of the IGC Chair on the Integrated Governance Committee.
16. To note the Report of the Director of Commissioning Development on the PCT Legacy Document.
CommitteReports, Minutes and Urgent Decisions
17. Reports
17.1 Joint Integrated Governance Committee Report
18. Minutes
To note the following minutes:
18.1 Clinical Commissioning Committee - 11/08/2011
18.2 South West Specialised Commissioning Group - 21/06/2011
18.3 South West Specialised Commissioning Group - 05/10/2011
19. Urgent Decisions
To note the following urgent decisions:
None.
20. Any Other Business
20.1 Approval of Sponsorship
21. Date and Time of next meeting
The next Joint meeting of NHS Dorset and NHS Bournemouth and Poole will take place on Tuesday 29 March 2012 at Vespasian House, Bridport Road, Dorchester, Dorset, DT1 1TS at 10.00 am.
Exclusion of the Public
To resolve that representatives of the Press and other members of the public, be excluded from the remainder of this meeting having regard to the confidential nature of the business to be transacted, publicity on which would be prejudicial to the public interest.


